Testing effectiveness (Phase 2)Study completedNCT00789685
What this trial is testing
Safety, Tolerability and Preliminary Efficacy of FP-1201 in ALI and ARDS. Phase I/II
Who this might be right for
Acute Lung InjuryAcute Respiratory Distress Syndrome
Faron Pharmaceuticals Ltd 37